Robert Sinnott Net Worth

The estimated Net Worth of Robert A Sinnott is at least $994 mil dollars as of 8 February 2024. Robert Sinnott owns over 1,545 units of Usana Health Sciences Inc stock worth over $172,905 and over the last 18 years he sold USNA stock worth over $821,278. In addition, he makes $0 as Chief Scientific Officer at Usana Health Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Robert Sinnott USNA stock SEC Form 4 insiders trading

Robert has made over 27 trades of the Usana Health Sciences Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he sold 3,945 units of USNA stock worth $183,679 on 5 March 2024.

The largest trade he's ever made was exercising 14,741 units of Usana Health Sciences Inc stock on 16 August 2018 worth over $965,241. On average, Robert trades about 2,542 units every 136 days since 2006. As of 8 February 2024 he still owns at least 4,638 units of Usana Health Sciences Inc stock.

You can see the complete history of Robert Sinnott stock trades at the bottom of the page.

Robert Sinnott biography

Dr. Robert A. Sinnott, M.N.S., Ph.D. is Chief Scientific Officer of the Company since August 2016. From 2005 to 2016, he was Chief Science officer of Mannatech, Inc. From 2009 to 2012, he also served as Co-Chief Executive Officer and from 2012 to 2016 as CEO of Mannatech. During his tenure at Mannatech, Dr. Sinnott served to further the company’s proprietary science, research and development, and initiated independent clinical trials, was responsible for oversight of quality assurance/quality control, global regulatory affairs, legal department, human resources, and global supply chain. Dr. Sinnott has held scientific and business positions in both industry and government over the past 25 years with experience in life sciences, chemistry, biotechnology and nutrition. For the past 18 years, he has worked directly in the dietary supplement industry both in the United States and internationally. From 2006 to 2011, Dr. Sinnott held a seat on the Board of Directors of the Council of Responsible Nutrition’s (the “CRN”), the leading trade association representing ingredient suppliers and manufacturers of dietary supplements. From 2009 to 2011, Dr. Sinnott also served as chair of the Senior Scientific Advisory Committee (SSAC) for the CRN. The SSAC is comprised of the highest-ranking scientific officers of member companies. Its role is to assist the CRN with development and implementation of scientific strategy relating to scientific publications, scientific policies and programs by government agencies. Dr. Sinnott holds a B.S. in Biological Sciences, an M.S. in Natural Science, and a Ph.D. in Plant Sciences from Arizona State University, in Tempe, Arizona. His focus was on applied biological sciences, including biotechnology and plant medicinal chemistry.

How old is Robert Sinnott?

Robert Sinnott is 56, he's been the Chief Scientific Officer of Usana Health Sciences Inc since 2016. There are 10 older and 12 younger executives at Usana Health Sciences Inc. The oldest executive at Usana Health Sciences Inc is Dr. Myron W. Wentz, 80, who is the Founder & Chairman Emeritus.

What's Robert Sinnott's mailing address?

Robert's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD, , SALT LAKE CITY, UT, 84120.

Insiders trading at Usana Health Sciences Inc

Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull, eMyron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.

What does Usana Health Sciences Inc do?

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su

Complete history of Robert Sinnott stock trades at Mannatech Inc e Usana Health Sciences Inc

Usana Health Sciences Inc executives and stock owners

Usana Health Sciences Inc executives and other stock owners filed with the SEC include:

• Kevin Guest,
  Chairman of the Board, Chief Executive Officer
• Jim Brown,
  President
• Kevin G. Guest,
  Chairman & CEO
• G Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Field Development Officer
• Walter Noot,
  Chief Operating Officer
• Jim Brown,
  Pres
• Daniel Macuga,
  Chief Communications and Marketing Officer
• G. Douglas Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Sales Officer
• Walter Noot,
  Chief Operating Officer
• Paul Jones,
  Chief Leadership Development Officer
• Peggie Pelosi,
  Independent Director
• Gilbert Fuller,
  Lead Independent Director
• Robert Anciaux,
  Senior Director
• Frederic Winssinger,
  Independent Director
• Feng Peng,
  Independent Director
• Timothy Wood,
  Independent Director
• Dr. Myron W. Wentz,
  Founder & Chairman Emeritus
• John Fleming,
  Director
• Brent Neidig,
  Chief Officer and Managing Director of China
• P. Joshua Foukas,
  Chief Legal Officer, General Counsel and Corporate Secretary
• Robert Sinnott,
  Chief Scientific Officer
• P. Joshua Foukas,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Patrique Richards,
  Exec. Director of Investor Relations & Bus. Devel.
• Dr. John Cuomo,
  Exec. Director of Product Devel. & Technology
• J Scott Nixon,
  Director
• Myron W Gull Global Ltd Wentz,
  
• Robert Auciaux,
  
• Global Ltd Gull,
  10% owner
• Myron W Wentz,
  CEO
• Deborah Woo,
  E.V.P. of Sales
• Donald R. Williams,
  Director
• Dave Wentz,
  President
• James Bramble,
  
• Jerry G Mcclain,
  Director
• Denis E Waitley,
  Director
• Roy Truett,
  Chief Information Officer
• Doug Braun,
  Chief Marketing Officer
• Ronald S Poelman,
  Director
• Rick Stambaugh,
  Chief Information Officer
• Holdings Ltd Gull,
  10% owner
• Fred W Cooper,
  Vice President of Operations
• Jeffrey Yates,
  Chief Financial Officer
• Mark H Wilson,
  V.P. of Customer Relations
• Bradford Richardson,
  E.V.P. of Asia Pacific
• G Doug Iiekking,
  CHIEF FINANCIAL OFFICER
• Peter Benedict,
  CHIEF INFORMATION OFFICER
• Joshua Foukas,
  CHIEF LEGAL OFFICER
• Xia Ding,
  Director